National shareholder rights firm Hagens Berman has launched an investigation into Alignment Healthcare following a whistleblower lawsuit alleging systemic financial manipulation. The lawsuit, filed by former chief transformation officer Hakan Kardes, claims the company misclassified operating expenses as capital expenditures to inflate adjusted EBITDA for 2024 and 2025, boosting key performance metrics tied to stock price and executive compensation. Alignment Healthcare's stock fell approximately 16.7% in a single day after the allegations became public on July 8, 2026, marking its worst single-day performance since February 2024. The decline came shortly after the company had reported strong first-quarter 2026 results and raised full-year guidance, driving shares toward 52-week highs. Hagens Berman is encouraging investors who suffered significant losses to contact the firm.
Alignment Healthcare LLCWhistleblower lawsuit alleging financial manipulation and investigation by shareholder rights firm.